ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    11 Years Experience of Early Steroid Withdrawal Immunosupression Protocol in Kidney Allograft Recipient

    O. Adebiyi, A. Sharfuddin, M. Yaqub, D. Mishler, T. Taber, W. Goggins

    Indiana University, Indianapolis, IN

    *Purpose: Early Steroid Withdrawal (ESW) Immunosuppression protocol has become a viable alternative to steroid based regimen. Our transplant program has adopted ESW protocol since 2003…
  • 2020 American Transplant Congress

    Molecular Diagnosis of Rejection in Liver Transplant Biopsies: The INTERLIVER Study

    K. S. Madill-Thomsen1, P. F. Halloran2, .. The INTERLIVER Study Group3

    1Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3., ., AB, Canada

    *Purpose: Diagnosing rejection in liver transplant biopsies is challenging given the limitations of histology e.g. low kappa values among pathologists. A Molecular Microscope® Diagnostic system…
  • 2020 American Transplant Congress

    Early Recurrence Of Hepatocellular Carcinoma Following Transplantation: Risk Score From A Multi-institutional Study Of > 3000 Patients

    P. Tabrizian1, M. Holzner2, V. Agopian3, R. Busuttil3, G. Sapisochin4, N. Mehta5, F. Yao5, J. Roberts6, S. Florman1, M. E. Schwartz1, T. Ivanics7, J. Emond8, B. Samstein9, R. Brown, MD, MPH9, M. Najjar10, W. Chapman11, M. Doyle11, K. Halazun9

    1Transplant, Mount Sinai Medical Center, New York, NY, 2Surgery, Georgetown University Hospital, Washington DC, MD, 3Transplant, David Geffen School of Medicine at UCLA, Los Angeles, CA, 4Transplant, Univeristy of Toronto, Toronto, ON, Canada, 5Transplant, UCSF, San Francisco, CA, 6Transplantation, UCSF, San Francisco, CA, 7Transplant, University of Toronto, Toronto, ON, Canada, 8Transplant, Columbia University Medical Center, New York, NY, 9Transplant, Weill Cornell Medical Center, New York, NY, 10Transplant, Columbia Medical Center, New York, NY, 11Transplant, Washington University School of Medicine, St Louis, MO

    *Purpose: Early recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) carries a poor prognosis. We aimed to develop a risk score for early HCC…
  • 2020 American Transplant Congress

    Live Donor Liver Transplant Offers Higher Survival, Improved Quality of Liver and Lower Morbidity for Recipients with Low MELD Score

    M. Black, J. Bayer, H. Fernandez, E. Martinez, G. McKenna, N. Onaca, R. Ruiz, G. Testa, A. Wall, T. Ma, G. Saracino, S. Asrani, A. Gupta

    Baylor University Medical Center, Dallas, TX

    *Purpose: The shortage of cadaveric liver grafts contributes to significant waitlist mortality. Patients with low MELD-Na score (
  • 2020 American Transplant Congress

    Assessment of Infectious Complications Following ABO-Blood Group Incompatible Renal Transplant

    J. Banbury1, T. Loosier1, C. Lin2, K. Gutierrez1

    1University of Alabama at Birmingham Hospital, Birmingham, AL, 2Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL

    *Purpose: In response to the ongoing organ shortage, ABO-incompatible (ABOi) renal transplant (RT) provides an alternative option for patients with end-stage kidney disease. Literature suggests…
  • 2020 American Transplant Congress

    Mycophenolate Mofetil and the Incidence of Skin Cancer in Kidney Transplant Recipients

    S. J. Yusuf1, H. Bheemreddy1, A. Imtiaz2, N. Krishnan3

    1Faculty of Health and Life Sciences, Coventry University, Coventry, United Kingdom, 2Dermatology, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom, 3Renal Unit, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

    *Purpose: Over the years there has been a shift in the use of anti-metabolites agents from azathioprine to mycophenolate mofetil (MMF) based immunosuppression., due to…
  • 2020 American Transplant Congress

    BK Viremia: A Double Edged Sword – The Impact of Immunosuppression Reduction on Allograft Rejection

    A. Szczepanik1, A. Bixby1, C. Burrelli1, A. Padiyar2, T. Srinivas2, K. Chavin3

    1Pharmacy, University Cleveland Medical Center, Cleveland, OH, 2Nephrology, University Cleveland Medical Center, Cleveland, OH, 3Surgery, University Cleveland Medical Center, Cleveland, OH

    *Purpose: BK viremia (BKV) increases the risk of renal allograft loss following transplant. Guidelines recommend reduction of immunosuppression (IS) after BKV diagnosis, however, the ideal…
  • 2020 American Transplant Congress

    Community Affluence Impacts Patient Survival Post Liver Transplantation

    D. Jorgensen, A. Humar, C. Hughes, M. Molinari, A. Ganoza, S. Ganesh, A. Duarte-Rojo, A. Tevar

    Surgery, University of Pittsburgh, Pittsburgh, PA

    *Purpose: Liver transplantation is an effective treatment for patients with end stage liver disease with excellent patients and grafts long term outcomes. Many recipient disease…
  • 2020 American Transplant Congress

    Comparison of Stanford Integrated Psychosocial Assessment for Transplantation Scores to Medication Adherence Assessment Findings in Kidney Transplant Candidates Undergoing Living Donor Transplant

    J. Trofe-Clark1, G. Malat1, M. Norris1, M. Bleicher2, E. Smith3, D. Sawinski2, R. Weinrieb4, R. Bloom2

    1Pharmacy, Hospital of Univ of Pennsylvania, Philadelphia, PA, 2Renal Division, Univ of Pennsylvania, Philadelphia, PA, 3Social Work, Hosp of Univ of Pennsylvania, Philadelphia, PA, 4Pyschiatry, Univ of Pennsylvania, Philadelphia, PA

    *Purpose: The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) is a standardized, evaluation tool intended to assess psychosocial health in organ transplant candidates. The purpose…
  • 2020 American Transplant Congress

    Bariatric Surgery to Achieve Sufficient Weight Loss for Heart Transplant Candidacy: Results of a Systematic Review and Meta-Analysis

    B. Orandi1, J. Purvis1, S. Mehta1, M. Gray1, S. Pamboukian1, J. Tallaj1, C. Hoopes1, C. Lewis1, N. Terrault2, J. Locke1

    1UAB, Birmingham, AL, 2USC, Los Angeles, CA

    *Purpose: As the obesity epidemic grows, it can be expected that an increasing number of heart failure patients will be precluded from heart transplant based…
  • « Previous Page
  • 1
  • …
  • 215
  • 216
  • 217
  • 218
  • 219
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences